Merck wins interim relief against Teva
The High Court in London has granted an interim injunction against Teva to stop it launching a generic version of efavirenz, even though Teva had done nothing more than get market authorisation
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
